iScriptTM Reverse Transcription Supermix, 100 x 20 microl rxns, 400 microl - 100 x 20 amp micro;l… and 2 more items

BIO-RAD Laboratories Inc has been awarded a contract by the University of Virginia under contract number A207_PO-0192530-V3, effective June 20, 2026. The cumulative contract value is $634. The primary deliverable is iScript Reverse Transcription Supermix, a molecular biology reagent containing reverse transcriptase, ribonuclease inhibitor, deoxynucleotide triphosphates, primers, magnesium chloride, and stabilizers. The order comprises 634 units of the iScript formulation in 100 x 20 microliter reaction formats with 4 x 100 microliter 5x supermix configurations.

The contract includes 50 reactions per unit and encompasses delivery to the University of Virginia buyer with associated shipping and packaging services. All deliverables are to be provided to the contracting organization's specified location in Virginia. No separate annual value or distinct performance period outside the award date is specified in the available contract documentation.